Home / Antineoplastic agent, CD123-directed cytotoxic fusion protein / Tagraxofusp
Back to Search

Tagraxofusp – Uses, Dosage, and Brands in UAE

Brand Name: ELZONRIS
Strength: 1000 mcg/ml | Form: Concentrate For Solution For Infusion
Price in UAE: AED 121921.50
Available in UAE pharmacies

About Tagraxofusp

Class: | Antineoplastic agent, CD123-directed cytotoxic fusion protein Use: | Treatment of adults and pediatric patients aged 2 years and older with blastic plasmacytoid dendritic cell neoplasm (BPDCN) Adult dose: | 12 mcg/kg administered as an intravenous infusion over 15 minutes on days 1, 3, and 5 of a 21-day cycle Pediatric dose: | 12 mcg/kg administered as an intravenous infusion over 15 minutes on days 1, 3, and 5 of a 21-day cycle (for patients aged 2 years and older) Side effects

Drug Class

Antineoplastic agent, CD123-directed cytotoxic fusion protein

Uses & Indications

Treatment of adults and pediatric patients aged 2 years and older with blastic plasmacytoid dendritic cell neoplasm (BPDCN)

Storage Requirements

Store refrigerated at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light; once diluted, use immediately or store at room temperature for no more than 24 hours

Manufacturer & Packaging

Manufacturer: Stemline Therapeutics, Inc., United States of America

Package Size

1 Glass Vial

Price & Supplier

Price in UAE: AED 121921.50

Dosage Information

Adult Dose

12 mcg/kg administered as an intravenous infusion over 15 minutes on days 1, 3, and 5 of a 21-day cycle

Pediatric Dose

12 mcg/kg administered as an intravenous infusion over 15 minutes on days 1, 3, and 5 of a 21-day cycle (for patients aged 2 years and older)

Side Effects

Edema, fatigue, pyrexia, nausea, headache, rash, hypotension, and infusion-related reactions

Contraindications & Precautions

Hypersensitivity to tagraxofusp or any component of the formulation; severe infusion-related reactions

Important Warnings

Risk of serious infusion-related reactions; monitor patients during infusion; risk of bleeding and thrombocytopenia; may cause tumor lysis syndrome; use caution in patients with hepatic impairment

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

View All Antineoplastic agent, CD123-directed cytotoxic fusion protein Medicines Browse All Categories